๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Farnesyltransferase inhibitors in myelodysplastic syndrome

โœ Scribed by E. J. Feldman


Book ID
107540139
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
93 KB
Volume
1
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Angiogenesis in myelodysplastic syndrome
โœ Pruneri, G; Bertolini, F; Soligo, D; Carboni, N; Cortelezzi, A; Ferrucci, P F; B ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 302 KB
Advances in the development of farnesylt
โœ Wenli Yang; Keith Del Villar; Jun Urano; Hiroshi Mitsuzawa; Fuyuhiko Tamanoi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

A variety of compounds that show promise in cancer chemotherapy and chemoprevention have been identified as farnesyltransferase inhibitors. These can be classified into mainly two different types of inhibitors, farnesyl diphosphate competitors and CAAX peptidomimetics. The former type acts by compet

Telomere length in myelodysplastic syndr
โœ Boultwood, J.; Fidler, C.; Kusec, R.; Rack, K.; Elliott, P.J. W.; Atoyebi, O.; C ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB

We have studied telomere length in the bone marrow cells or the granulocyte and lymphocyte cell fractions of 54 patients with myelodysplastic syndromes (MDS) by Southern blot hybridization using the (TTAGGG)4 probe. The average telomere length expressed as the peak telomere repeat array (TRA) in the

Immunologic indices in myelodysplastic s
โœ Philippe H. Colombat; Micheline Renoux; Jean-Pierre Lamagnere; Gerory Renoux ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 586 KB
Clonality in the Myelodysplastic Syndrom
โœ Jacqueline Boultwood; James S. Wainscoat ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Carden Jennings Publishing ๐ŸŒ English โš– 67 KB